Rates of and Risk Factors for Adverse Drug Events in Outpatient Parenteral Antimicrobial Therapy | Zendy

Sara C. Keller | Zendy; Deborah Williams | Zendy; Mitra Gavgani | Zendy; David Hirsch | Zendy; John Adamovich | Zendy; Dawn Hohl | Zendy; Ayşe P. Gürses | Zendy; Sara E. Cosgrove | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Rates of and Risk Factors for Adverse Drug Events in Outpatient Parenteral Antimicrobial Therapy

Author(s) -

Sara C. Keller,

Deborah Williams,

Mitra Gavgani,

David Hirsch,

John Adamovich,

Dawn Hohl,

Ayşe P. Gürses,

Sara E. Cosgrove

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix733

Subject(s) - medicine , vancomycin , adverse effect , confidence interval , prospective cohort study , bacteremia , emergency medicine , intensive care medicine , antibiotics , staphylococcus aureus , biology , microbiology and biotechnology , bacteria , genetics

To better monitor patients on outpatient parenteral antimicrobial therapy (OPAT), we need an improved understanding of risk factors for and timing of OPAT-associated adverse drug events (ADEs).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research